James Horscroft, PhD
Principal Insight Analyst
James joined BresMed in 2016 and specialises in expert elicitation and rare diseases. During his PhD, he worked in ideation and innovation of drugs for orphan metabolic diseases and conducted pre-clinical studies investigating potential treatments for obesity and ischaemia/reperfusion injury.
James has worked on HTA submissions, including submissions to NICE’s Highly Specialised Technologies Committee. He has also provided strategic input into market access planning and led expert elicitation projects involving surveys, interviews and Delphi panels relating to a range of therapeutic areas including immuno-oncology, ophthalmology and orphan diseases.